RESUMEN
Transdermal delivery provides numerous benefits over conventional routes of administration. However, this strategy is generally limited to a few molecules with specific physicochemical properties (low molecular weight, high potency, and moderate lipophilicity) due to the barrier function of the stratum corneum layer. Researchers have developed several physical enhancement techniques to expand the applications of the transdermal field; among these, microneedle technology has recently emerged as a promising platform to deliver therapeutic agents of any size into and across the skin. Typically, hydrophilic biomolecules cannot penetrate the skin by passive diffusion. Microneedle insertion disrupts skin integrity and compromises its protective function, thus creating pathways (microchannels) for enhanced permeation of macromolecules. Microneedles not only improve stability but also enhance skin delivery of various biomolecules. Academic institutions and industrial companies have invested substantial resources in the development of microneedle systems for biopharmaceutical delivery. This review article summarizes the most recent research to provide a comprehensive discussion about microneedle-mediated delivery of macromolecules, covering various topics from the introduction of the skin, transdermal delivery, microneedles, and biopharmaceuticals (current status, conventional administration, and stability issues), to different microneedle types, clinical trials, safety and acceptability of microneedles, manufacturing and regulatory issues, and the future of microneedle technology.
RESUMEN
Pigs act as the intermediate hosts of the zoonotic tapeworms Taenia solium and Taenia asiatica, as well as of the non-zoonotic Taenia hydatigena. In Vietnam, human taeniasis and cysticercosis have been reported throughout the country; however, data on porcine cysticercosis are scarce. Our study aimed to estimate the prevalence of Taenia spp. in slaughtered pigs in two districts in Phu Tho, a mountainous province in northern Vietnam from where neurocysticercosis patients commonly originate. The carcasses of 399 pigs from 51 small-scale abattoirs were checked for cysticerci, while tongue, liver, masseter muscles, diaphragm and heart were sliced and examined. Retrieved cysticerci underwent polymerase chain reaction-restriction fragment length polymorphism and sequencing for species confirmation. Blood was also collected to detect antibodies by lentil lectin-purified glycoprotein enzyme-linked immunoelectrotransfer blot (LLGP-EITB) and recombinant T24H antigen (rT24H)-EITB and circulating antigens by B158/B60 Ag-ELISA. In two pigs, T. asiatica cysticerci were found, confirming the presence of the parasite in pigs in Vietnam at a low prevalence (0.5%; 95% exact confidence interval (CI): 0-1.19%). Cysticerci of T. solium were found in none of the pigs, although one serum sample was positive for antibodies in both LLGP-EITB and rT24H-EITB. Furthermore, a high prevalence of T. hydatigena cysticercosis was observed (18.0%; 95% Wilson score CI: 14.6-22.1%). In more than half of the T. hydatigena-positive pigs, circulating antigens were detected by Ag-ELISA, confirming that this test cannot be used to diagnose T. solium cysticercosis in this region. Finally, Spirometra erinaceieuropaei was found in one pig liver. It is the first record of this zoonotic cestode species in pigs in Vietnam. Overall, the findings confirmed the complex epidemiology of Taenia spp. in pigs in Vietnam.
Asunto(s)
Enfermedades de los Porcinos/parasitología , Taenia/aislamiento & purificación , Teniasis/epidemiología , Mataderos , Animales , Anticuerpos Antihelmínticos/sangre , Humanos , Carne/parasitología , Polimorfismo de Longitud del Fragmento de Restricción , Prevalencia , Porcinos , Enfermedades de los Porcinos/epidemiología , Taenia/clasificación , Teniasis/parasitología , Vietnam/epidemiologíaRESUMEN
The root of Polygonum multiflorum (also called He-Shou-Wu in Chinese) is a common herb and medicinal food in Asia used for its anti-aging properties. Our study investigated the therapeutic potential of an extract of the root of Polygonum multiflorum (PME) in allergic asthma by using a mouse model. Feeding of 0.5 and 1 mg/mouse PME inhibited ovalbumin (OVA)-induced allergic asthma symptoms, including airway inflammation, mucus production, and airway hyper-responsiveness (AHR), in a dose-dependent manner. To discern PME's mechanism of action, we examined the profile and cytokine production of inflammatory cells in bronchial alveolar lavage fluid (BALF). We found that eosinophils, the main inflammatory cell infiltrate in the lung of OVA-immunized mice, significantly decreased after PME treatment. Th2 cytokine levels, including interleukin (IL)-4, IL-5, IL-13, eotaxin, and the proinflammatory cytokine tumor necrosis factor (TNF)-[Formula: see text], decreased in PME-treated mice. Elevated mRNA expression of Th2 transcription factor GATA-3 in the lung tissue was also inhibited after oral feeding of PME in OVA-immunized mice. Thus, we conclude that PME produces anti-asthma activity through the inhibition of Th2 cell activation.
Asunto(s)
Antiasmáticos/farmacología , Asma/tratamiento farmacológico , Fallopia multiflora/química , Fitoterapia , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Administración Oral , Animales , Asma/metabolismo , Asma/patología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Femenino , Factor de Transcripción GATA3/metabolismo , Mediadores de Inflamación/metabolismo , Pulmón/metabolismo , Ratones Endogámicos BALB C , Moco/metabolismo , Ovalbúmina , Raíces de PlantasRESUMEN
Semisolid matrix capsule formulations of verapamil HCl and diltiazem HCl prepared by hot-melt capsule filling are an especially appealing and simple way to make sustained-release formulations. Semisolid matrices of Gelucire 50/13 and stearic acid combination eroded and disintegrated at various rates, depending on the combination of waxes, and drug release rates were dependent on storage time (2.5 years) and temperature. Semisolid matrices of combinations of only Gelucire 50/13 and cetyl alcohol eroded at a rate much less than combinations of Gelucire 50/13 and stearic acid. The drug release mechanism from Gelucire 50/13: stearic acid matrices involved diffusion and erosion, whereas Gelucire 50/13 and cetyl alcohol matrices exhibited a diffusion mechanism only. A combination of Gelucire 50/13 with cetyl alcohol is more effective than stearic acid in appropriately extending verapamil HCl release from semisolid matrix capsules. The semisolid matrix formulations studied are sensitive to dissolution stirring speeds.
Asunto(s)
Diltiazem/química , Verapamilo/química , Cápsulas , Química Farmacéutica , Preparaciones de Acción Retardada , Diltiazem/administración & dosificación , Solubilidad , Verapamilo/administración & dosificaciónRESUMEN
Ethnobotany/ethnopharmacology has contributed to the discovery of many important plant-derived drugs. Field explorations to seek and document indigenous/traditional medical knowledge (IMK/TMK), and/or the biodiversity with which the IMK/TMK is attached, and its conversion into a commercialized product is known as bioprospecting or biodiversity prospecting. When performed in a large-scale operation, the effort is referred to as mass bioprospecting. Experiences from the mass bioprospecting efforts undertaken by the United States National Cancer Institute, the National Cooperative Drug Discovery Groups (NCDDG) and the International Cooperative Biodiversity Groups (ICBG) programs demonstrate that mass bioprospecting is a complex process, involving expertise from diverse areas of human endeavors, but central to it is the Memorandum of Agreement (MOA) that recognizes issues on genetic access, prior informed consent, intellectual property and the sharing of benefits that may arise as a result of the effort. Future mass bioprospecting endeavors must take heed of the lessons learned from past and present experiences in the planning for a successful mass bioprospecting venture.
Asunto(s)
Etnobotánica , Etnofarmacología , Propiedad Intelectual , Conservación de los Recursos Naturales , Etnobotánica/ética , Etnobotánica/tendencias , Etnofarmacología/ética , Etnofarmacología/tendencias , Humanos , Medicina TradicionalRESUMEN
This article describes a biosensor based on pH-sensitive field-effect transistors (pH-FETs) as transducer, and immobilised enzyme tyrosinase as biorecognition element, which was used for the determination of phenolic compounds in water solutions. The biologically active membrane was formed by cross-linking of tyrosinase with bovine serum albumin (BSA) in saturated glutaraldehyde (GA) vapours on the sensitive transducer surface. The main analytical characteristics were studied under different conditions as well as the possibility to optimise these working parameters. Different factors such as the pH of immobilisation, the enzyme loading, the time of exposition to glutaraldehyde vapours were investigated in regards to the influence on sensitivity, limit of detection, dynamic range, and operational and storage stability.
Asunto(s)
Técnicas Biosensibles , Concentración de Iones de Hidrógeno , Fenoles/análisis , Enzimas Inmovilizadas/química , Monofenol Monooxigenasa/química , Potenciometría , Sensibilidad y EspecificidadRESUMEN
An enzyme biosensor for the determination of 4-chlorophenol in water solutions based on potentiometric pH-sensitive field-effect transistors as semiconductor transducer and tyrosinase immobilised in saturated glutaraldehyde vapours as biorecognition element has been described for the first time. The main analytical characteristics were studied under different conditions, as well as the possibility to optimise these working parameters. Different factors, such as pH of immobilisation, the enzyme loading and time of immobilisation in glutaralaldehyde vapours were investigated with regard to the influence on sensitivity, limit of detection, dynamic range, and operational and storage stability. The best result gives a limit of detection close to 20 ppm and a dynamic range from 25 to 1000 ppm with sensitivity 2 mV mM(-1). The operational stability was not less-than15 h and the R.S.D. were approximately 3% for intra-sensors responses and approximately 7% for inter-sensors responses. The storage stability was >15 days.
Asunto(s)
Suero Antilinfocítico/uso terapéutico , Rechazo de Injerto/prevención & control , Trasplante de Corazón/fisiología , Inmunosupresores/uso terapéutico , Adolescente , Adulto , Anciano , Animales , Azatioprina/uso terapéutico , Niño , Monitoreo de Drogas , Quimioterapia Combinada , Femenino , Rechazo de Injerto/patología , Trasplante de Corazón/inmunología , Trasplante de Corazón/mortalidad , Humanos , Recuento de Linfocitos , Masculino , Metilprednisolona/uso terapéutico , Persona de Mediana Edad , Conejos , Estudios Retrospectivos , Tasa de SupervivenciaAsunto(s)
Trasplante de Corazón/estadística & datos numéricos , Infecciones/epidemiología , Complicaciones Posoperatorias/epidemiología , Adulto , Infecciones Bacterianas/epidemiología , Quimioterapia Combinada , Femenino , Rechazo de Injerto/epidemiología , Trasplante de Corazón/inmunología , Trasplante de Corazón/mortalidad , Hospitales Universitarios , Humanos , Enfermedad Iatrogénica/epidemiología , Inmunosupresores/uso terapéutico , Infecciones/clasificación , Masculino , Persona de Mediana Edad , Micosis/epidemiología , Infecciones por Protozoos/epidemiología , Estudios Retrospectivos , Tasa de Supervivencia , Taiwán , Virosis/epidemiologíaRESUMEN
AIM: To evaluate the effectiveness of triple therapy containing either omeprazole or ranitidine bismuth citrate (RBC) to treat H. pylori infection in Vietnamese duodenal ulcer patients. METHODS: Patients infected with H. pylori were randomized to receive either omeprazole (20 mg b.d.), clarithromycin (500 mg b.d.) and amoxycillin (1 g b.d.) for 10 days (OAC), or RBC (400 mg b.d.), clarithromycin (500 mg b.d.) and amoxycillin (1 g b.d.) for 10 days (RAC). H. pylori eradication and ulcer healing was established by a follow-up oesophagogastroduodenoscopy (EGD) at least 4 weeks after therapy. Side-effects and compliance were assessed. RESULTS: One hundred and four out of 108 (96%) patients with a duodenal ulcer were infected with H. pylori. Eighty per cent of infected patients had detectable CagA IgG antibodies. Fifty-seven patients received OAC and 47 received RAC. OAC eradicated H. pylori in 91 and 86% of patients by per protocol (PP) and intention-to-treat (ITT) analysis, respectively. PP and ITT eradication rates for RAC were 96 and 91%. Ulcer healing at the follow-up EGD was 89% with OAC and 100% with RAC. Side-effects were minor. No patient failed to complete the protocol due to side-effects. CONCLUSION: Triple therapy with either omeprazole or RBC is highly effective in eradicating H. pylori and healing duodenal ulcer in Vietnamese patients.
Asunto(s)
Antiulcerosos/uso terapéutico , Bismuto/uso terapéutico , Úlcera Duodenal/tratamiento farmacológico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , Omeprazol/uso terapéutico , Ranitidina/análogos & derivados , Adolescente , Adulto , Anciano , Antiulcerosos/efectos adversos , Antígenos Bacterianos/inmunología , Proteínas Bacterianas/inmunología , Bismuto/efectos adversos , Úlcera Duodenal/inmunología , Úlcera Duodenal/microbiología , Femenino , Infecciones por Helicobacter/inmunología , Infecciones por Helicobacter/microbiología , Humanos , Inmunoglobulina A/análisis , Masculino , Persona de Mediana Edad , Omeprazol/efectos adversos , Cooperación del Paciente , Ranitidina/efectos adversos , Ranitidina/uso terapéutico , Ureasa/análisis , VietnamRESUMEN
OBJECTIVES: To assess the prevalence of current or previous infection with viral hepatitis agents in an older nursing home population. DESIGN: A prospective cohort study. SETTING: Three nursing homes in the greater St. Louis area affiliated with Saint Louis University. SUBJECTS: Older residents admitted to these facilities. MEASUREMENTS: Residents were interviewed and examined for evidence of hepatitis or liver disease. Serum samples were tested for hepatitis B surface antigen (HBsAg), antibody to hepatitis B core and surface antigens (anti-HBc and anti-HBs), antibody to hepatitis A virus (anti-HAV), antibody to hepatitis C virus (anti-HCV), and hepatitis G virus RNA (HGV RNA). RESULTS: Of 329 residents queried, 199 gave consent and were able to participate. The seroprevalence of hepatitis was: HBsAg 0%, anti-HBc 24.1%, anti-HBs 19.5%, anti-HAV 79.9%, anti-HCV 4.5%, and HGV-RNA 10.6%. Frequency of HAV infection increased significantly with age whereas HBV infection correlated with ethnic status and former occupation as a manual worker. A history of blood transfusion was associated with a higher rate of anti-HCV. End stage renal disease, present in 17 patients, was associated with anti-HBc, anti-HCV, and HGV RNA positivity but not with anti-HBs or anti-HAV positivity CONCLUSIONS: The seroprevalence of anti-HCV was surprisingly high in this population residing in skilled nursing facilities, and we recommend that all new patients admitted to this type of institution be screened for anti-HCV. The prevalence of HGV RNA was higher than in the general US blood donor population, but the significance of this finding remains uncertain.
Asunto(s)
Hepatitis Viral Humana/epidemiología , Hogares para Ancianos , Distribución por Edad , Anciano , Anciano de 80 o más Años , Transfusión Sanguínea , Femenino , Hepacivirus/inmunología , Anticuerpos Antihepatitis/sangre , Antígenos de la Hepatitis B/sangre , Hepatitis Viral Humana/virología , Humanos , Fallo Renal Crónico , Masculino , Persona de Mediana Edad , Missouri/epidemiología , Estudios Prospectivos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Estudios Seroepidemiológicos , Instituciones de Cuidados Especializados de EnfermeríaRESUMEN
OBJECTIVE: To target medically ill older home care patients with symptoms of depression in order to reduce their rate of hospitalization. DESIGN: A case-control study. SETTING: A private, nonprofit home care organization, the Visiting Nurse Association of St. Louis. PARTICIPANTS: Home care patients 65 years of age and older with symptoms of depression who were participants of a Total Quality Management (TQM) intervention (n = 81) were compared with an historical control of home care patients 65 years of age and older with symptoms of depression (n = 69). INTERVENTION: Utilization of TQM principles to develop a plan including: (a) an educational seminar on depression for home care staff involved in the project; (b) letters to physicians introducing the TQM project; (c) use of the Geriatric Depression Scale (GDS) for screening; (d) recommendation to the primary physician of a home social service (SS) consultation for patients with a GDS of 10 to 14; (e) recommendation to the primary physician of three interventions for patients with a GDS > or = 15: home SS consultation + mental health (MH), or gerontological nurse (GN) consultation + antidepressant medication (a pharmacotherapeutic algorithm sent by facsimile to the primary physician upon request). OUTCOME MEASURES: Hospitalization rates of the control group compared with the TQM intervention group, the degree to which part (e) of the plan was implemented, and the effect this had on hospitalization rates. RESULTS: The TQM intervention patients had a higher mean age than the historical control patients but were not different in percent female, percent white race, percent with a caregiver in the home, functional status, and in 15 of 16 diagnostic categories. Overall, the TQM intervention group had a hospitalization rate of 23.5% (19/81) compared with a rate of 40.6% (28/69) for the historical control group (P = .024). For part (e) of the plan (56/81 patients had a GDS > or = 15), 29/56 (52%) received the recommended SS consultation, 50/56 (89%) received the recommended MH or GN consultation, and 32/56 (57%) received antidepressant medication. One type of intervention did not seem to lower hospitalization rates more than another although having received the MH or GN visits approached significance (12/50, 24%; P = .052) when compared with the control group. CONCLUSIONS: Utilization of TQM principles and the development of an intervention such as the one described here can decrease hospitalization rates for medically ill older home care patients with symptoms of depression.
Asunto(s)
Depresión/terapia , Servicios de Atención de Salud a Domicilio , Hospitalización/estadística & datos numéricos , Gestión de la Calidad Total , Anciano , Anciano de 80 o más Años , Antidepresivos/uso terapéutico , Estudios de Casos y Controles , Enfermería en Salud Comunitaria , Femenino , Humanos , MasculinoRESUMEN
Ag binding to the membrane Ig (mIg) substructure of the B cell Ag receptor leads to activation of cytoplasmic effector molecules including blk, fyn, lyn, and/or lck tyrosine kinases that are associated with receptor's dimeric Ig-alpha/Ig-beta transducer substructure. The structural basis of the apparent intermolecular transmission of this information within the receptor complex is unknown. Here we report that conservative point mutation of a sequence, S584-K597, at the cytoplasmic end of the predicted transmembrane spanning domain of the mIgM heavy chain (mu) ablates Ag-activated signal transduction, while having no detectable effect on association of mIgM with Ig-alpha/Ig-beta heterodimers. Specifically, mutation of serine584 to alanine, tyrosine587 to phenylalanine, threonine592 to valine, or lysine597 to isoleucine completely abrogated Ag-induced signal transduction leading to protein tyrosine phosphorylation and Ca2+ mobilization. Interestingly, mutants in the more peripheral of these residues, serine584 to alanine and lysine597 to isoleucine, remained responsive to a monoclonal antireceptor Ab (b-7-6) and all mutants remained responsive to polyclonal antireceptor Ab. These data implicate the polar sequence, -Y587STTVT592-, in transfer of information from ligand binding to transducer substructures within this heterooligomeric receptor complex. They further indicate that receptor activation by ligands that bind with high affinity and/or to constant region mIg epitopes is less dependent on the integrity of this motif.
Asunto(s)
Inmunoglobulina M/fisiología , Mutación Puntual , Receptores de Antígenos de Linfocitos B/fisiología , Transducción de Señal , Secuencia de Aminoácidos , Secuencia de Bases , Calcio/metabolismo , Datos de Secuencia Molecular , Fosforilación , Tirosina/metabolismoAsunto(s)
Linfocitos B/química , Estructura Secundaria de Proteína , Estructura Terciaria de Proteína , Receptores de Antígenos de Linfocitos B/química , Receptores de Antígenos de Linfocitos B/fisiología , Secuencia de Aminoácidos , Animales , Linfocitos B/fisiología , Comunicación Celular , Humanos , Inmunoglobulinas/fisiología , Proteínas de la Membrana/fisiología , Datos de Secuencia Molecular , Conformación Proteica , Transducción de Señal , Relación Estructura-ActividadRESUMEN
Recent animal studies have suggested that there exists an activated subpopulation of circulating granulocytes which plays an important part in microvascular sequestration and tissue injury during shock and ischemia. In this respect, spontaneous granulocyte activation in form of pseudopod formation, a manifestation of actin polymerization, is a high risk for microvascular entrapment. The present investigation was carried out to determine if there is a significant difference in pseudopod formation in vitro between granulocytes obtained from healthy volunteers without symptoms and patients with acute cardiovascular illnesses. Blood samples from 25 healthy volunteers, 12 patients with acute myocardial infarction (AMI) and 12 patients with acute cerebral infarction (ACI) to determine spontaneous pseudopod formation in granulocytes with a high resolution light microscope over a period of several hours. The results revealed that the mean percentage of cells with pseudopod formation in the control group was below 10% in the first 3 hours, and increased to about 50% at 12 hours. In AMI patients, the level of activation within the first hour was not significantly different from the controls, but it rose rapidly to 90% in 4 to 5 hours. Patients with cerebral infarction, however, showed no significant difference from the control group. When the granulocytes of healthy subjects were incubated in plasma of AMI, the cells were activated similar to AMI granulocytes in their own plasma. When AMI plasma was serially diluted with Ringer's solution, the activation curve fell successively. These results indicate that AMI patients' blood contains plasma factor(s) which can activate granulocytes at a more rapid rate than controls.
Asunto(s)
Infarto Cerebral/sangre , Granulocitos/fisiología , Infarto del Miocardio/sangre , Células Cultivadas , Granulocitos/ultraestructura , Humanos , Neutrófilos/ultraestructura , Seudópodos/ultraestructura , Factores de TiempoRESUMEN
CD45 is a member of a family of membrane proteins that possess phosphotyrosine phosphatase activity, and is the source of much of the tyrosine phosphatase activity in lymphocytes. In view of its enzymatic activity and high copy number, it seems likely that CD45 functions in transmembrane signal transduction by lymphocyte receptors that are coupled to activation of tyrosine kinases. The B cell antigen receptor was found to transduce a Ca(2+)-mobilizing signal only if cells expressed CD45. Also, both membrane immunoglobulin M (mIgM) and CD45 were lost from the surface of cells treated with antibody to CD45, suggesting a physical interaction between these proteins. Finally, CD45 dephosphorylated a complex of mIg-associated proteins that appears to function in signal transduction by the antigen receptor. These data indicate that CD45 occurs as a component of a complex of proteins associated with the antigen receptor, and that CD45 may regulate signal transduction by modulating the phosphorylation state of the antigen receptor subunits.
Asunto(s)
Antígenos de Diferenciación/fisiología , Linfocitos B/inmunología , Antígenos de Histocompatibilidad/fisiología , Glicoproteínas de Membrana/fisiología , Receptores de Antígenos de Linfocitos B/fisiología , Transducción de Señal , Animales , Antígenos de Diferenciación/genética , Calcio/fisiología , Línea Celular , Membrana Celular/fisiología , Células Cultivadas , Células Clonales , Antígenos de Histocompatibilidad/genética , Inmunoglobulina M/fisiología , Antígenos Comunes de Leucocito , Ratones , Fosfoproteínas Fosfatasas/metabolismo , Fosforilación , Plasmacitoma , Proteínas Tirosina Fosfatasas , ARN Mensajero/genética , Bazo/inmunología , TransfecciónAsunto(s)
Receptores de Antígenos de Linfocitos B/inmunología , Receptores Fc , Secuencia de Aminoácidos , Animales , Genes de Inmunoglobulinas/genética , Humanos , Inmunoglobulina G/genética , Inmunoglobulina M/genética , Activación de Linfocitos/inmunología , Datos de Secuencia Molecular , Receptores de Antígenos de Linfocitos B/genética , Receptores Inmunológicos/genética , Receptores Inmunológicos/inmunología , Alineación de Secuencia , Homología de Secuencia de Ácido NucleicoRESUMEN
Assessment of antibodies against human T-lymphotropic virus type I (HTLV-I) by enzyme-linked immunoassay, immunofluorescence, and Western blot was undertaken in patients with pathologically or clinically diagnosed acquired immunodeficiency syndrome-related vacuolar myelopathy to determine whether this retrovirus could be etiologically implicated in this disorder. No serological evidence for HTLV-I was found in the patients with vacuolar myelopathy, though 1 patient with an atypical myelopathy did have antibodies against HTLV-I.
Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/complicaciones , Enfermedades Desmielinizantes/etiología , Infecciones por HTLV-I/complicaciones , Enfermedades de la Médula Espinal/etiología , Síndrome de Inmunodeficiencia Adquirida/inmunología , Enfermedades Desmielinizantes/inmunología , Anticuerpos Anti-HTLV-I , Humanos , Enfermedades de la Médula Espinal/inmunologíaRESUMEN
To study the molecular basis for antibody diversity and the structural basis for antigen binding, we have characterized the loss of phosphocholine (P-Cho) binding both experimentally and computationally in U10, a somatic mutant of the antibody S107. Nucleotide sequencing of U10 shows a single base change in JH1, substituting Asp-101 with Ala, over 9 A distant from the P-Cho-binding pocket. Probing with antiidiotypic antibodies suggests local, not global, conformational changes. Computational results support a specific structural mechanism for the loss of P-Cho binding. The U10 mutation eliminates the charged interaction between Asp-101 and Arg-94, which allows the Arg-94 side chain to disrupt P-Cho binding sterically and electrostatically by folding into the P-Cho-binding site. These results specifically show the importance of the Arg-94 to Asp-101 side chain salt bridge in the heavy-chain CDR3 conformation and suggest that residues distant from the binding site play an important role in antibody diversity and inducible complementarity.